Business schools are in the grips of a scandal that threatens to undermine their most influential research—and the ...

Cédric Lemarchand and colleagues highlight weaknesses in the evidence on efficacy and safety of hallucinogens and question the use of expedited regulatory pathways The US clinical market for ketamine, ...